CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare leukemia: targeted pill shows promise in early trial
Disease control OngoingThis study tests a drug called cobimetinib in people with a rare blood cancer (CMML) that has certain gene mutations. The goal is to see if the drug can shrink or control the cancer. The trial includes 14 adults who are either newly diagnosed or whose cancer stopped responding to…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
Could a targeted drug boost transplant success in tough blood cancers?
Disease control OngoingThis early-phase study tests whether adding the drug venetoclax to standard transplant preparation and post-transplant maintenance can safely help prevent cancer return in people with high-risk acute myeloid leukemia, myelodysplastic syndromes, or related blood cancers. About 102…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 14, 2026 12:03 UTC